Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation. Atorvastatin was more effective in lowering cholesterol and had fewer side effects than cerivastatin. Comparison of the efficacy of atorvastatin versus cerivastatin in primary hypercholesterolemia. Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. Cardiovascular benefits associated with tea drinking varied among countries.
Digoxin benefits for heart failure patients are independent of age.
Eptifibatide reduced myocardial infarction following percutaneous intervention among patients without, but not among patients with, procedural complications. A randomized trial comparing Multilink stents with GFX stents. Current data suggests caution when prescribing these for CHD patients. Risk of cardiovascular events associated with selective COX-2 inhibitors.